Carcinogenesis 23, 13991404
This pricing model removes the financial barrier to optimizing therapy when plateaus occur
Primary antibodies to DPEP-1 (Proteintech, #12222-1-AP, 1:1000), 4-HNE (Abcam, #ab46545, 1:1000), FTH1 (Abcam, #ab65080, 1:1000), GCLM (Abcam, #EPR6667, 1:1000), GCLC (Abcam, #EP13475, 1:2000), ZBP1 (Adipogen, #AG-20B-0010-c100, 1:1000), FSP1 (Santa Cruz, #sc-377120, 1:5000), and -actin (Cell Signaling, #3700S, 1:500) were diluted in skimmed milk (Carl Roth, #T145.2)
J Clin Endocrinol Metab 91, 35483552 (2006)
however, no change in medication or dose was allowed
See Batch Specific COA Below) Form: Synthetic Peptide Powder Available in 5 mg or 10 mg vials This product is intended strictly for laboratory research use only